TILs therapy

tumor-infiltrating lymphocytes · Tianjin Medical University General Hospital

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TILs therapy, covering 2026-03-27 to 2026-03-27. Get the full timeline:

Most recent: Clinical Trial Update: TILs Therapy for Multiple Primary Early-Stage NSCLC [EARLY_Phase 1]